A multi-site case study of community-clinical linkages for promoting HPV vaccination
- PMID: 31158042
- PMCID: PMC6746520
- DOI: 10.1080/21645515.2019.1616501
A multi-site case study of community-clinical linkages for promoting HPV vaccination
Abstract
Human papillomavirus (HPV) vaccination rates in the U.S. are suboptimal, requiring innovative partnerships between community and clinical entities to remedy this issue. A rigorous evaluation of HPV-related community-clinical linkages (CCLs) was conducted to understand their components, processes, and outcomes to increase HPV vaccination. Cancer Prevention and Control Research Network (CPCRN) investigators explored CCLs in their communities employing an iterative, case study approach. Information describing nine CCLs on HPV vaccination was collected from representatives from the community organization and clinical setting. Thematic content analysis was used to analyze and interpret data. Five CCLs included a federally qualified health center as the clinical partner, and five included a non-profit organization as the community partner. Five reflected clinically focused integration wherein engagement occurs in the community but vaccine delivery and follow-up occur in the clinical setting. The main impetus was the need to improve HPV vaccination and a community's strong interest in preventing cancer. Noted critical components were a designated person to support the CCL and funding. Results will guide HPV vaccination promotion, education, and intervention efforts. CCLs provide an opportunity to study the adaption, integration, and enhancement of evidence-based approaches to increase HPV vaccination.
Keywords: Community health services; cervical cancer; community networks; health services; prevention; vaccination.
References
-
- Centers for Disease Control and Prevention How many cancers are linked with HPV each year? Atlanta (GA): Division of Cancer Prevention and Control; 2018. August 15 [accessed 2018October12]. http://www.cdc.gov/cancer/hpv/statistics/cases.htm
-
- Centers for Disease Control and Prevention Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2011;60(50):1705–08. - PubMed
-
- Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE.. Centers for disease control and prevention. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64:300–04. - PMC - PubMed
-
- Centers for Disease Control and Prevention For parents of preteens and teens: vaccines for your children. Atlanta (GA): National Center for Immunization and Respiratory Diseases; 2016. April 1 [[accessed 2018October12]. https://www.cdc.gov/vaccines/parents/diseases/teen/index.html
-
- The Henry J. Kaiser Family Foundation The HPV vaccine: access and use in the U.S. San Francisco (CA): The Henry J. Kaiser Family Foundation; 2018. [accessed 2018 October12October9]. http://kff.org/womens-health-policy/fact-sheet/the-hpv-vaccine-access-an...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical